These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20684863)

  • 21. Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo.
    Tang SH; Huang HS; Wu HU; Tsai YT; Chuang MJ; Yu CP; Huang SM; Sun GH; Chang SY; Hsiao PW; Yu DS; Cha TL
    Oncotarget; 2014 Nov; 5(21):10342-55. PubMed ID: 25431950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer.
    Choi JH; Song YS; Yoon JS; Song KW; Lee YY
    APMIS; 2010 Mar; 118(3):196-202. PubMed ID: 20132185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.
    Qazi AM; Gruzdyn O; Semaan A; Seward S; Chamala S; Dhulipala V; Sethi S; Ali-Fehmi R; Philip PA; Bouwman DL; Weaver DW; Gruber SA; Batchu RB
    Surgery; 2012 Oct; 152(4):704-11; discussion 711-3. PubMed ID: 22943841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.
    Bao B; Ali S; Banerjee S; Wang Z; Logna F; Azmi AS; Kong D; Ahmad A; Li Y; Padhye S; Sarkar FH
    Cancer Res; 2012 Jan; 72(1):335-45. PubMed ID: 22108826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice.
    Murakami M; Nagai E; Mizumoto K; Saimura M; Ohuchida K; Inadome N; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Int J Cancer; 2005 Oct; 117(1):160-5. PubMed ID: 15880501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
    Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
    Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
    Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
    Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo.
    Guo J; Cai J; Yu L; Tang H; Chen C; Wang Z
    Cancer Sci; 2011 Mar; 102(3):530-9. PubMed ID: 21205084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
    Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of RNAi-mediated STAT3 gene inhibition on metastasis of human pancreatic cancer cells].
    Gao Z; Huang C; Qiu ZJ; Jiang T; Zhu L; Cao J; Zhang F; Huang KJ
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1010-3. PubMed ID: 19035205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.
    Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP
    Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.
    Vernejoul F; Faure P; Benali N; Calise D; Tiraby G; Pradayrol L; Susini C; Buscail L
    Cancer Res; 2002 Nov; 62(21):6124-31. PubMed ID: 12414637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Snail recruits Ring1B to mediate transcriptional repression and cell migration in pancreatic cancer cells.
    Chen J; Xu H; Zou X; Wang J; Zhu Y; Chen H; Shen B; Deng X; Zhou A; Chin YE; Rauscher FJ; Peng C; Hou Z
    Cancer Res; 2014 Aug; 74(16):4353-63. PubMed ID: 24903147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells.
    Wagener N; Holland D; Bulkescher J; Crnković-Mertens I; Hoppe-Seyler K; Zentgraf H; Pritsch M; Buse S; Pfitzenmaier J; Haferkamp A; Hohenfellner M; Hoppe-Seyler F
    Int J Cancer; 2008 Oct; 123(7):1545-50. PubMed ID: 18623083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EZH2 depletion blocks the proliferation of colon cancer cells.
    Fussbroich B; Wagener N; Macher-Goeppinger S; Benner A; Fälth M; Sültmann H; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2011; 6(7):e21651. PubMed ID: 21765901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma.
    Chen Y; Lin MC; Wang H; Chan CY; Jiang L; Ngai SM; Yu J; He ML; Shaw PC; Yew DT; Sung JJ; Kung HF
    Proteomics; 2007 Sep; 7(17):3097-104. PubMed ID: 17676662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.